Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M119,056Revenue $M22,156Net Margin (%)32.6Altman Z-Score2.8
Enterprise Value $M119,230EPS $9.5Operating Margin %39.9Piotroski F-Score8
P/E(ttm)16.8Beneish M-Score-2.5Pre-tax Margin (%)37.7Higher ROA y-yY
Price/Book4.210-y EBITDA Growth Rate %11.8Quick Ratio4.2Cash flow > EarningsY
Price/Sales5.65-y EBITDA Growth Rate %17.6Current Ratio4.4Lower Leverage y-yY
Price/Free Cash Flow14.4y-y EBITDA Growth Rate %28.0ROA % (ttm)10.1Higher Current Ratio y-yN
Dividend Yield %2.1PEG1.0ROE % (ttm)26.0Less Shares Outstanding y-yY
Payout Ratio %35.0Shares Outstanding M752ROIC % (ttm)21.3Gross Margin Increase y-yY

Gurus Latest Trades with AMGN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AMGNKen Fisher 2016-03-31 Reduce-0.01%$140.9 - $162.33
($148.76)
$ 158.306%Reduce -17.38%112,693
AMGNJoel Greenblatt 2015-12-31 Reduce-0.18%$141.22 - $164.58
($157.65)
$ 158.300%Reduce -31.85%276,751
AMGNFirst Eagle Investment 2015-12-31 Add0.17%$141.22 - $164.58
($157.65)
$ 158.300%Add 73.61%957,656
AMGNVanguard Health Care Fund 2015-12-31 Reduce-0.05%$141.22 - $164.58
($157.65)
$ 158.300%Reduce -3.25%5,398,985
AMGNGeorge Soros 2015-12-31 Add0.01%$141.22 - $164.58
($157.65)
$ 158.300%Add 109.52%4,400
AMGNDodge & Cox 2015-12-31 Reduce$141.22 - $164.58
($157.65)
$ 158.300%Reduce -3.52%46,644
AMGNMario Gabelli 2015-12-31 Reduce$141.22 - $164.58
($157.65)
$ 158.300%Reduce -3.39%39,175
AMGNKen Fisher 2015-12-31 Add$141.22 - $164.58
($157.46)
$ 158.301%Add 2.07%136,400
AMGNJoel Greenblatt 2015-09-30 Reduce-0.07%$132.24 - $176.59
($157.63)
$ 158.300%Reduce -11.55%406,106
AMGNFirst Eagle Investment 2015-09-30 Add0.04%$132.24 - $176.59
($157.63)
$ 158.300%Add 22.77%551,600
AMGNKen Fisher 2015-09-30 Reduce-0.01%$132.24 - $176.59
($157.63)
$ 158.300%Reduce -13.84%133,632
AMGNMario Gabelli 2015-09-30 Reduce$132.24 - $176.59
($157.63)
$ 158.300%Reduce -0.06%40,550
AMGNGeorge Soros 2015-09-30 Buy $132.24 - $176.59
($157.63)
$ 158.300%New holding2,100
AMGNDodge & Cox 2015-09-30 Reduce$132.24 - $176.59
($157.63)
$ 158.300%Reduce -4.84%48,344
AMGNRuane Cunniff 2015-09-30 Add$132.24 - $176.59
($157.63)
$ 158.300%Add 24.74%2,017
AMGNJoel Greenblatt 2015-06-30 Add0.19%$151.6 - $169.17
($160.19)
$ 158.30-1%Add 48.52%459,125
AMGNFirst Eagle Investment 2015-06-30 Reduce-0.02%$151.6 - $169.17
($160.19)
$ 158.30-1%Reduce -9.71%449,294
AMGNKen Fisher 2015-06-30 Reduce$151.6 - $169.17
($160.19)
$ 158.30-1%Reduce -0.97%155,101
AMGNMario Gabelli 2015-06-30 Add$151.6 - $169.17
($160.19)
$ 158.30-1%Add 1.48%40,575
AMGNDodge & Cox 2015-06-30 Reduce$151.6 - $169.17
($160.19)
$ 158.30-1%Reduce -7.13%50,804
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AMGN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


AMGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Bradway Robert AChairman, CEO and President 2016-03-02Sell20,000$146.488.07view
de Carbonnel FrancoisDirector 2015-08-31Sell5,000$153.842.9view
Hassan FredDirector 2015-08-19Buy3,010$166.63-5view
PELHAM JUDITH CDirector 2015-07-31Sell5,035$180.4-12.25view
Patton Cynthia MSVP & CCO 2015-06-02Sell4,530$157.060.79view
Balachandran MadhavanEVP, Operations 2015-05-07Sell21,750$157.870.27view
Tross Stuart ASVP, Human Resources 2015-04-23Sell3,012$169.31-6.5view
Harper Sean EEVP, Research & Development 2015-04-22Sell28,000$171.58-7.74view
Tross Stuart ASVP, Human Resources 2015-03-03Sell4,415$157.740.36view
BALTIMORE DAVIDDirector 2015-03-02Sell3,647$158.76-0.29view

Press Releases about AMGN :

Quarterly/Annual Reports about AMGN:

News about AMGN:

Articles On GuruFocus.com
Does Biotech’s Recent Bounce Have Legs? Apr 22 2016 
Dan Loeb's Third Point Portfolio Highly Concentrated Apr 01 2016 
Daniel Loeb's Third Point Portfolio Highly Concentrated Mar 31 2016 
Citigroup, Amgen Are Trading With Wide Margin of Safety Mar 30 2016 
Amgen: Should I Just Sit and Wait? Mar 18 2016 
Gilead, Johnson & Johnson or Roche? Feb 11 2016 
Plenty of Opportunity to Buy Individual Stocks: John Buckingham Feb 02 2016 
Alan Fournier Sells GM, Buys Molson Coors Brewing Jan 03 2016 
Analyzing Amgen's Dividend Hike Dec 20 2015 
Allergan Among Health Care Holdings in Alan Fournier's Portfolio Dec 15 2015 

More From Other Websites
Top Trades: Biotech's brutal week Apr 29 2016
5 way to trade the mixed biotech sector Apr 29 2016
US stocks hit by health care woes but avoid bigger losses Apr 29 2016
US stocks hit by health care woes but avoid bigger losses Apr 29 2016
A Typical Bad First Quarter For Biotech: Leerink Apr 29 2016
What Are Analysts Saying About Q1 At Biotech's Big 4? Amgen, Biogen, Celgene, Gilead Apr 29 2016
Amgen (AMGN) Tops Q1 Earnings & Revenues, Ups View Apr 29 2016
Pfizer Earnings Could Highlight Enbrel and Lyrica Sales Decline Apr 29 2016
Edited Transcript of AMGN earnings conference call or presentation 28-Apr-16 9:30pm GMT Apr 29 2016
Amgen posts 1Q sales, profit jumps, raises profit forecasts Apr 28 2016
Amgen posts 1Q sales, profit jumps, raises profit forecasts Apr 28 2016
Amgen profit sails past Street expectations; raises 2016 outlook Apr 28 2016
Q1 Earnings Reports Continue the Deluge: AMZN, GILD, AMGN Apr 28 2016
[$$] Amgen Profit Rises 17%, Guidance Raised Apr 28 2016
Amgen (AMGN) Beats Q1 Earnings Estimates, Raises 2016 Outlook Apr 28 2016
After Hours: Amazon, LinkedIn, Baidu, Expedia Soar, Gilead Flops Apr 28 2016
Amgen Inc Earnings Call scheduled for 5:30 pm ET today Apr 28 2016
Amgen Legacy Drugs Drive Q1 Beat; Gilead Hep C Juggernaut Stumbles Apr 28 2016
AMGEN INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Apr 28 2016
Amgen (AMGN) Stock Higher in After-Hours Trading on Q1 Beat, Guidance Apr 28 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)